Creative Medical Technology Holdings (CELZ) Restructuring Costs (2010 - 2015)

Creative Medical Technology Holdings (CELZ) has reported Restructuring Costs for 6 consecutive years, with $925.0 the latest figure, recorded in Q4 2015.

• On a quarterly basis, Restructuring Costs rose 60.87% year-over-year to $925.0 in Q4 2015; TTM through Mar 2016 was $925.0, a 19.35% increase from a year earlier, with the FY2015 full-year figure at $1025.0, up 36.67% from the prior year.
• Restructuring Costs was $925.0 for Q4 2015 at Creative Medical Technology Holdings, up from $100.0 in the prior quarter.
• Over five years, Restructuring Costs peaked at $925.0 in Q4 2015 and troughed at $75.0 in Q1 2014.
• A 5-year average of $424.5 and a median of $384.5 in 2011 frame the typical range for Restructuring Costs.
• Across the five-year window, Restructuring Costs soared 596.72% in 2011 and sank 48.45% in 2012, its largest moves.
• Over 5 years, Restructuring Costs stood at $850.0 in 2011, then decreased by 11.76% to $750.0 in 2012, then dropped by 23.33% to $575.0 in 2013, then changed by 0.0% to $575.0 in 2014, then surged by 60.87% to $925.0 in 2015.
• The last three Restructuring Costs figures came in at $925.0 (Q4 2015), $100.0 (Q1 2015), and $575.0 (Q4 2014), per Business Quant data.